Ingunn Dybedal
4PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jan 28, 2026
Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study.Jason Gotlib, Andreas Reiter, Deepti H Radia
|Aug 14, 2024
How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms.Panagiotis Baliakas, Bianca Tesi, Jörg Cammenga
|Nov 28, 2023
Pathogenic DDX41 variants, possible response predictors to low-dose melphalan in hypo- and normocellular MDS and AML.Otto Emil Nyquist, Jakob Dalgaard, Signe Spetalen
|May 31, 2022
Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis.Andreas Reiter, Juliana Schwaab, Daniel J DeAngelo
Pageof 1
Frequent Collaborators
2 joint publications
Daniel J DeAngelo
2 joint publications
Michael W Deininger
2 joint publications
Alessandro M Vannucchi
2 joint publications
Jens Panse
2 joint publications
Panagiotis Baliakas
1 joint publications
Uwe Platzbecker
1 joint publications
Otto Emil Nyquist
1 joint publications
Bianca Tesi
1 joint publications
Jörg Cammenga
1 joint publications
Asbjørg Stray-Pedersen
